Valley Baptist Medical Center-Harlingen offers a new way to treat a patient for a cerebral aneurysm, using the Surpass Streamline Flow Diverter device.
“We are excited to have successfully implanted one of the first Surpass Flow Diverters in Texas, right here in the Rio Grande Valley,” said Ameer E. Hassan, M.D., DO, FAHA, FSVIN, Head of the Neuroscience Department, Director of Endovascular Surgical Neuroradiology and Director of Clinical Neuroscience Research at Valley Baptist -Harlingen.
Valley Baptist-Harlingen is advancing the way patients with large and unruptured aneurysms are treated by using the latest stent to reliably keep the artery open and close the blood flow to the aneurysm.
“We are committed to advancing the treatment for patients suffering from intracranial aneurysms,” said Dr. Hassan. “Due to the location of these aneurysms, they can pose a challenge to access and treatment. The Surpass provides a less invasive form of intervention to treat these patients.”
The Surpass Streamline Flow Diverter was FDA approved in 2018 and is the second flow diverting stent to gain FDA approval in the United States. It is a small cobalt chromium-braided stent that is used to direct blood flow within an intracranial artery away from a weakened blood vessel sac or aneurysm.
“Aneurysms left untreated can lead to serious health problems, such as cerebral hemorrhage, stroke, brain damage, coma and even death,” said Dr. Hassan. “This is a serious health condition that should receive immediate treatment.”
According to the Brain Aneurysm Foundation, an estimated six million people in the United States have an unruptured brain aneurysm, of which approximately 25,000 are treated with endovascular or surgical treatments each year.
“Every day, we are making advancements and finding new ways to treat patients with neurological conditions,” said Dr. Hassan.